NCT03988764 (ADDAM) is a clinical trial of None AHT in Diabetes Mellitus, Type 1, sponsored by McGill University Health Centre/Research Institute of the McGill University Health Centre.

What drugs are being tested in NCT03988764?

Interventions in NCT03988764: None AHT.

What condition does NCT03988764 study?

NCT03988764 studies Diabetes Mellitus, Type 1, Monogenic Diabetes, Neonatal Diabetes, Maturity-onset Diabetes in the Young (MODY), Wolfram Syndrome, Wolcott-Rallison Syndrome, Mitochondrial Diabetes.

Is NCT03988764 still recruiting?

NCT03988764 is currently recruiting now. Last updated 10 December 2024.

Last reviewed 2024-12-10 · How we verify

NCT03988764: ADDAM

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Monogenic Diabetes Misdiagnosed as Type 1

Recruiting now Last updated 10 December 2024

What this trial tests

trial testing None AHT in Diabetes Mellitus, Type 1 in 5,000 participants. Currently enrolling.

Timeline

24 September 2019

Primary endpoint
31 December 2025

31 December 2025

Quick facts

Lead sponsor	McGill University Health Centre/Research Institute of the McGill University Health Centre
Status	Recruiting now
Study type	OBSERVATIONAL
Enrollment	5,000
Start date	24 September 2019
Primary completion	31 December 2025
Estimated completion	31 December 2025
Sites	1 location across Canada

Drugs / interventions tested

None AHT — full drug profile →

Conditions studied

Diabetes Mellitus, Type 1 — all drugs for Diabetes Mellitus, Type 1 →
Monogenic Diabetes — all drugs for Monogenic Diabetes →
Neonatal Diabetes — all drugs for Neonatal Diabetes →
Maturity-onset Diabetes in the Young (MODY) — all drugs for Maturity-onset Diabetes in the Young (MODY) →

Sponsor

McGill University Health Centre/Research Institute of the McGill University Health Centre

Who can join

Adults 1 Day to 25, any sex, with Diabetes Mellitus, Type 1 or Monogenic Diabetes. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study has two aims: 1. To (1a) determine the frequency of monogenic diabetes misdiagnosed as type 1 diabetes (T1D) and (2) to define an algorithm for case selection. 2. To discover novel genes whose mutations cause monogenic diabetes misdiagnosed as T1D.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Monogenic Causes in the Type 1 Diabetes Genetics Consortium Cohort: Low Genetic Risk for Autoimmunity in Case Selection.
Marchand L, Li M, Leblicq C, Rafique I, et al · · 2021 · cited 13× · PMID 33538814 · DOI 10.1210/clinem/dgab056

Verify or expand the search:

Other trials of None AHT

Trials testing the same drug.

NCT07527377 — Operating Room Nurses' Knowledge of Medical Device-Related Pressure Injuries and Clinical Decision-Making Skills · not yet recruiting
NCT06924463 — Identification of Specific Molecular Signatures in Pediatric, Adolescent, and Young Adult Rhabdomyosarcoma Through Spati · recruiting

Other recruiting trials for Diabetes Mellitus, Type 1

Currently open trials in the same condition.

NCT07325461 — Feasibility Study of Extended Wear Insulin Infusion Set Options During Home Use in People With Type 1 Diabetes · NA · recruiting
NCT07305805 — A Research Study of a New Medicine NNC0363-1063 in Participants With Type 1 Diabetes · Phase 1 · recruiting
NCT06282055 — Trajectories in Insulin Sensitivity Across MEnstrual cycleS in Women With Type 1 Diabetes · recruiting
NCT06325202 — Closed Loop and Education for Hypoglycemia Awareness Restoration · NA · recruiting
NCT07160816 — A Research Study to See How Insulin Icodec Helps People With Type 1 Diabetes Control Their Blood Sugar · recruiting

Other McGill University Health Centre/Research Institute of the McGill University Health Centre trials

Trials by the same sponsor.

NCT07439406 — Comparing Standard and Autoclaved Peanut Oral Immunotherapy in People With Peanut Allergy · Phase 2 · not yet recruiting
NCT07328971 — Vancomycin Taper to Prevent Recurrent Clostridioides Difficile · Phase 3 · not yet recruiting
NCT07556952 — Dex & Mastectomy Pain · Phase 4 · recruiting
NCT07069582 — Pharmacokinetics of Antituberculosis Drugs in Breastfeeding Women · Phase 1 · not yet recruiting
NCT07386171 — Micro-Ultrasound for Detecting Clinically Significant Prostate Cancer in Active Surveillance · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03988764 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by McGill University Health Centre/Research Institute of the McGill University Health Centre
Last refreshed: 10 December 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03988764.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing